South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Also, the FDA approved Merilog’s 3-milliliter single-patient-use prefilled pen and a 10-milliliter ... rely on daily injections of insulin for treatment of diabetes, having a biosimilar option ...

Quality scores dipped during the COVID-19 pandemic, but are now at or above 2019 levels in areas such as diabetes and asthma management.

After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...

"There’s been a real shortage of these products, particularly since they share production with, for example, the diabetes and weight-loss products." Aspen is adding the ability to make pens and may ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

the diabetes and weight-loss products.” Aspen is adding the ability to make pens and may yet get rights to manufacturer insulin pens, Saad added. South Africa’s regulator has also been called ...